Endonovo Names Ira Weisberg President to Guide Global Medical Expansion
30 nov. 2022 09h07 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today named Ira Weisberg as President and Chief Commercial Officer of its Medical Division. “Ira will...
ENDONOVO ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES FOR ITS SOFPULSE® MEDICAL DEVICE ASSETS
17 nov. 2022 09h07 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced plans to explore strategic alternatives to maximize the shareholder value potential of...